FDA advisory panel approves 'pink Viagra'
The drug nicknamed "pink Viagra" just cleared a major regulatory hurdle. An FDA advisory panel today gave the green light to flibanserin, a drug designed to increase the sex drive of women with low libido, reports the Los Angeles Times
. The same panel rejected the drug twice previously. Today'...